Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Ascletis Pharma has received FDA Investigational New Drug clearance to begin a Phase I clinical trial of ASC35, a once-monthly subcutaneous dual peptide agonist for obesity treatment.
Redox has launched new AI features for its interoperability platform, including an MCP server and an AI Assistant Suite, to help healthcare organizations automate integration workflows and improve data readiness.
ProofPilot has introduced STUDY RAIDAR, an AI intelligence layer within its platform that analyzes clinical trial data to identify risks and generate operational recommendations for sponsors and research teams.
Oracle Health and Theator announced a collaboration to bring AI-based surgical intelligence solutions to U.S. hospitals, aiming to automate operative reporting and improve documentation accuracy through video analysis and integration with electronic health records.
Infosys has announced a collaboration with Sentara Health to build an AI foundation across hospital operations, IT, and clinical support, using its Topaz Fabric framework to embed AI in enterprise workflows and improve efficiency.
Veeva Systems has acquired Copli and introduced Veeva Falcon MLR, an agentic medical, legal, and regulatory solution designed to automate content review in the life sciences sector.
Grow Therapy has announced a research collaboration with Stanford University to create evidence-based standards ensuring the safe use of AI in mental health care. The study will test leading AI models' responses to mental health crises and evaluate methods to reduce harm in sensitive scenarios.
Diagnostic.ly has launched new at-home diagnostics capabilities that add automated test-to-treatment workflows and a patent-pending AI specimen collection observation system to its platform.
Ladder Health has raised $7 million in a seed round led by Nina Capital to expand its AI-enabled pediatric therapy platform across several U.S. states, aiming to reduce long wait times for developmental care.
Zeta Surgical and HOPE Therapeutics have treated the first patient using the FDA-cleared Zeta TMS Navigation System, which applies AI and computer vision to guide transcranial magnetic stimulation therapy with high precision.
Attunio Health has introduced a precision psychiatry platform that combines AI, biomarker testing, and wearable monitoring to personalize mental health treatment and provide continuous clinical feedback.
The Advanced Research Projects Agency for Health awarded up to $39.3 million to Children's Hospital of Philadelphia and collaborators to create a wearable system that uses AI to detect low fetal oxygen during labor.
ChemT Biotechnology has raised $4 million in seed funding led by Wavemaker Ventures, with participation from SEEDS and other investors, to expand its AI and experimental infrastructure for biomanufacturing.
Tredence has acquired KMK Consulting, a New Jersey-based analytics and consulting firm serving major pharmaceutical companies, to accelerate growth in healthcare and life sciences. The company expects the sector to contribute 25% of its revenue by 2028.
Brenig Therapeutics will present new data on its AI designed brain-penetrant NLRP3 inhibitor BT-409 at the Keystone Symposia on Neuroinflammation in Health and Disease, showcasing how its Hybrid AI Platform supports CNS drug discovery.
DropGenie has closed a Seed+ financing round led by Skeleton Key with participation from Merck Global Health Innovation Fund and CQDM to support the commercial launch of its first gene editing product.
ChartSpan has completed the acquisition of Validic, integrating Validic’s health data technology with ChartSpan’s care management services to create a unified platform for continuous patient monitoring and proactive clinical care.
A paper in Alzheimer's & Dementia highlights SpeechDx's role in developing AI tools that use speech patterns to detect early cognitive decline and support personalized Alzheimer's care.
AnHorn Medicines announced that its neuroprotective candidate AH-008 has received U.S. FDA IND clearance and Taiwan CDE Index Case designation, enabling the company to begin clinical trials for preventing chemotherapy-induced peripheral neuropathy.
Co-Diagnostics hosted a delegation from its Saudi joint venture CoMira Diagnostics in Salt Lake City for the unveiling of a future automated PCR test kit manufacturing line, part of a planned technology transfer to Saudi Arabia.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
